PharMerica Corporation (PMC)


NYSE - NYSE Real Time Price. Currency in USD
27.91+0.25 (+0.90%)
At close: 4:02 PM EDT
People also watch:
KNDLHCGABCMOHPRXL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open27.67
Prev Close27.66
Bid27.90 x 1000
Ask27.91 x 2000
Day's Range27.22 - 27.92
52wk Range19.79 - 35.81
1y Target EstN/A
Market Cap858.65M
P/E Ratio (ttm)28.83
Beta3.21
Volume178,409
Avg Vol (3m)291,568
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals23 hours ago

    Trump or Clinton? What the presidential race means for health care companies

    Presidential candidates often are measured in ballots and polls — but what about stocks? According to the report, managed care companies, such as Aetna Inc. and Louisville-based Humana Inc., likely would do well under either candidate, but especially under Trump. Clinton has said she wants to try to fix the exchanges , possibly by creating a public option to compete with insurers.

  • TheStreet.com4 months ago

    5 Health Care Stocks John Paulson Is Betting On in 2016

    When it comes to investing in health care, hedge fund pro John Paulson knows his stuff.

  • American City Business Journalslast month

    What can Pharmerica do to get buyers to swipe right?

    According to an analyst report from Credit Suisse, PharMerica Corp. needs to do some primping if it wants to attract a buyer. Reports swirled last week that PharMerica (PMC) was exploring strategic alternatives including a potential sale. The analyst report might as well say, "we told you so." Credit Suisse has been talking about a potential PharMerica sale since at least March, when it talked about how the institutional pharmacy could "enhance its allure to a potential acquirer," or at least bulk up business.